Medicine & Life Sciences
4-phenyl-1,2,3,6-tetrahydropyridine
100%
Primates
62%
Neuroimaging
60%
Apathy
57%
Dopamine
56%
Haplorhini
41%
Ventral Tegmental Area
40%
dihydrotetrabenazine
39%
Positron-Emission Tomography
31%
Cerebral Cortex
31%
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
28%
methyl ester (1R-(exo,exo))-3-(4-fluorophenyl)-8-methyl-8- azabicyclo(3.2.1)octane-2-carboxylic acid
20%
Prefrontal Cortex
20%
fluorodopa F 18
18%
Tegmentum Mesencephali
15%
Dopamine Plasma Membrane Transport Proteins
13%
Neurotoxins
12%
Parkinsonian Disorders
12%
Nucleus Accumbens
12%
Substantia Nigra
12%
Parkinson Disease
9%
Cell Count
8%
Aptitude
7%
Magnetic Resonance Imaging
7%
Regression Analysis
7%
Animals
5%
Agriculture & Biology
dopamine
67%
positron-emission tomography
64%
animal models
58%
monkeys
48%
prefrontal cortex
39%
cortex
36%
Parkinson disease
18%
magnetic resonance imaging
17%
pathophysiology
16%
neurotoxins
16%
Primates
11%
transporters
11%
dosage
6%
animals
5%
Chemical Compounds
Positron
78%
Dopamine
63%
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
36%
Tropane
32%
Neurotoxin
27%
Dose
17%